Join Us On Facebook.
Follow us on Twitter.
Clearview News Wire
Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
Top court rejects Pfizer punitive damages appeal
June 22, 2010
Top court rejects Pfizer punitive damages appealLast Updated: 2010-06-21 13:00:24 -0400 (Reuters Health)
WASHINGTON (Reuters) - The Supreme Court rejected Pfizer Inc's appeal of a ruling that ordered a retrial on how much punitive damages should be awarded to a woman who developed breast cancer after taking the company's hormone replacement therapy drugs.
Pfizer in its appeal argued that a retrial limited to just punitive damages had violated its constitutional right to a jury trial and that the trial judge in the case had improperly admitted the testimony of a scientific expert.
An Arkansas jury in 2008 sided with Donna Scroggin in her lawsuit against two Pfizer units - Wyeth and Upjohn. She was diagnosed with breast cancer in 2000, after taking hormone replacement therapy drugs for 11 years.
The jury awarded her compensatory damages of $2.7 million and punitive damages of $19.4 million against Wyeth and $7.8 million against Upjohn.
A U.S. appeals court upheld the jury's award of compensatory damages and said a federal judge had correctly set aside the punitive damages award against Upjohn as a matter of law. The appeals court ordered a new trial on punitive damages involving Wyeth.
Pfizer in its appeal opposed a partial retrial limited to punitive damages, saying it would lead to confusion and uncertainty for the jury and would be a denial of its right to a fair trial.
The pharmaceutical company and legal groups supporting it said the appeals court should have ordered an entirely new trial.
On Monday, the Supreme Court rejected the company's appeal without any comment
In 2002, the National Institutes of Health published the results of its study that linked the use of hormone replacement therapy to breast cancer.
Last Updated: 2010-06-21 13:00:24 -0400 (Reuters Health)
WASHINGTON (Reuters) - The Supreme Court rejected Pfizer Inc's appeal of a ruling that ordered a retrial on how much punitive damages should be awarded to a woman who developed breast cancer after taking the company's hormone replacement therapy drugs.
Pfizer in its appeal argued that a retrial limited to just punitive damages had violated its constitutional right to a jury trial and that the trial judge in the case had improperly admitted the testimony of a scientific expert.
An Arkansas jury in 2008 sided with Donna Scroggin in her lawsuit against two Pfizer units - Wyeth and Upjohn. She was diagnosed with breast cancer in 2000, after taking hormone replacement therapy drugs for 11 years.
The jury awarded her compensatory damages of $2.7 million and punitive damages of $19.4 million against Wyeth and $7.8 million against Upjohn.
A U.S. appeals court upheld the jury's award of compensatory damages and said a federal judge had correctly set aside the punitive damages award against Upjohn as a matter of law. The appeals court ordered a new trial on punitive damages involving Wyeth.
Pfizer in its appeal opposed a partial retrial limited to punitive damages, saying it would lead to confusion and uncertainty for the jury and would be a denial of its right to a fair trial.
The pharmaceutical company and legal groups supporting it said the appeals court should have ordered an entirely new trial.
On Monday, the Supreme Court rejected the company's appeal without any comment
In 2002, the National Institutes of Health published the results of its study that linked the use of hormone replacement therapy to breast cancer.
Tweet
Other Articles:
- February 3, 2012
- Senators urge Komen to reconsider funding decision
- February 1, 2012
- Eating fish tied to lower risk of colon polyps
- January 31, 2012
- Kids seek tans, use less sunscreen as they Age
- January 18, 2012
- FDA approves BTG's drug for cancer toxicity
- January 5, 2012
- Argentina's Fernandez undergoes cancer surgery
- December 20, 2011
- Vitamin D has mixed effects on cancer, broken bones
- December 13, 2011
- Memory issues after cancer may not be due to chemo
- December 8, 2011
- Quicker radiation therapy doubles mastectomy risk
- December 7, 2011
- Prostate cancer hormonal therapy cuts deaths: report
- November 17, 2011
- More fruit tied to lower risk of uterine fibroids
- November 15, 2011
- Brain scan study finds evidence of 'chemo brain'
- November 9, 2011
- No link between selenium, lower lung cancer risk
- November 8, 2011
- Singer Andy Williams reveals he has cancer
- November 7, 2011
- More evidence obesity tied to colon cancer
- November 4, 2011
- More evidence obesity tied to colon cancer
- October 31, 2011
- Heavy drinking tied to higher stomach cancer risk
- October 28, 2011
- Heavy drinking tied to higher stomach cancer risk
- October 27, 2011
- Doctors split on Avastin for breast cancer: survey
- October 21, 2011
- More breast cancer diagnosed in women with diabetes
- October 20, 2011
- US health panel cautious on HPV screening vs Pap
- October 19, 2011
- Girls' HPV vaccination rates falling short
- October 18, 2011
- Should your hairdresser screen you for skin cancer?
- October 14, 2011
- Flaxseed may not cool hot flashes
- October 12, 2011
- Vitamin E tied to higher risk of prostate cancer
- October 10, 2011
- Antioxidants tied to mixed effects in breast cancer